PT98735A - Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem

Info

Publication number
PT98735A
PT98735A PT98735A PT9873591A PT98735A PT 98735 A PT98735 A PT 98735A PT 98735 A PT98735 A PT 98735A PT 9873591 A PT9873591 A PT 9873591A PT 98735 A PT98735 A PT 98735A
Authority
PT
Portugal
Prior art keywords
preparing
pharmaceutical compositions
compositions containing
compounds
azacyclic compounds
Prior art date
Application number
PT98735A
Other languages
English (en)
Other versions
PT98735B (pt
Inventor
Per Sauerberg
Preben H Olesen
Charles H Mitch
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PT98735A publication Critical patent/PT98735A/pt
Publication of PT98735B publication Critical patent/PT98735B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
PT98735A 1990-08-21 1991-08-21 Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem PT98735B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK198490A DK198490D0 (da) 1990-08-21 1990-08-21 Heterocykliske forbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
PT98735A true PT98735A (pt) 1992-08-31
PT98735B PT98735B (pt) 1999-01-29

Family

ID=8109268

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98735A PT98735B (pt) 1990-08-21 1991-08-21 Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem

Country Status (18)

Country Link
US (2) US5328923A (pt)
EP (1) EP0544714B1 (pt)
JP (1) JP3100159B2 (pt)
AT (1) ATE130611T1 (pt)
AU (1) AU660938B2 (pt)
CA (1) CA2089770A1 (pt)
DE (1) DE69114848T2 (pt)
DK (2) DK198490D0 (pt)
ES (1) ES2079075T3 (pt)
FI (1) FI930746A (pt)
GR (1) GR3018479T3 (pt)
IE (1) IE73873B1 (pt)
IL (1) IL99146A (pt)
NO (1) NO302415B1 (pt)
NZ (1) NZ239475A (pt)
PT (1) PT98735B (pt)
WO (1) WO1992003431A1 (pt)
ZA (1) ZA916580B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5622976A (en) * 1991-12-31 1997-04-22 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
CZ285030B6 (cs) * 1993-08-19 1999-05-12 Novo Nordisk A/S Použití thiadiazolových a oxadiazolových sloučenin pro výrobu farmaceutického prostředku a farmacetický prostředek pro léčení schizofrenie nebo schizofrenních nemocí
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5545638A (en) * 1993-12-21 1996-08-13 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
IL112024A (en) * 1993-12-21 1999-07-14 Novo Nordisk As Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
EP0910566B1 (en) * 1996-04-24 2003-09-17 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
AU2307899A (en) * 1997-12-23 1999-07-12 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
EP1983560A2 (en) * 2001-07-10 2008-10-22 Shin-Etsu Handotai Company Limited Method for manufacturing a silicon epitaxial wafer
CN1821243B (zh) * 2005-08-30 2010-12-08 北京大学 取代的吡啶类m1受体激动剂、其制备方法及其用途
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
US5017618A (en) * 1987-03-16 1991-05-21 University Of Florida Labile derivatives of ketone analogs of 3-substituted-1-alkylamino-2-propanols and their use as beta-adrenergic blockers
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0322182A3 (en) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
EP0544714A1 (en) 1993-06-09
NZ239475A (en) 1994-08-26
JPH06500541A (ja) 1994-01-20
ES2079075T3 (es) 1996-01-01
US5328923A (en) 1994-07-12
AU8422991A (en) 1992-03-17
GR3018479T3 (en) 1996-03-31
DK0544714T3 (da) 1996-04-09
DE69114848D1 (de) 1996-01-04
ZA916580B (en) 1992-05-27
JP3100159B2 (ja) 2000-10-16
IL99146A (en) 1998-01-04
AU660938B2 (en) 1995-07-13
PT98735B (pt) 1999-01-29
DK198490D0 (da) 1990-08-21
ATE130611T1 (de) 1995-12-15
NO930600D0 (no) 1993-02-19
IE73873B1 (en) 1997-07-02
FI930746A (fi) 1993-03-26
WO1992003431A1 (en) 1992-03-05
IE912959A1 (en) 1992-02-26
EP0544714B1 (en) 1995-11-22
CA2089770A1 (en) 1992-02-22
US5591755A (en) 1997-01-07
DE69114848T2 (de) 1996-07-18
IL99146A0 (en) 1992-07-15
FI930746A0 (fi) 1993-02-19
NO930600L (no) 1993-04-16
NO302415B1 (no) 1998-03-02

Similar Documents

Publication Publication Date Title
PT98734A (pt) Processo de preparacao de compostos 1,2,5,6-tetra-hidropiridina e de composicoes farmaceuticas que os contem
PT98736A (pt) Processo de preparacao de compostos de piperidina e de composicoes farmaceuticas que os contem
PT98735A (pt) Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
FI954131A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920410

FG3A Patent granted, date of granting

Effective date: 19981027

MM3A Annulment or lapse

Effective date: 20060427